Evaluation of feasibility and applicability of current EASL-EASD-EASO and DGVS guidelines for diagnosis of Non-Alcoholic Fatty Liver disease in Patients with Type 2 Diabetes mellitus.
- Conditions
- Fatty (change of) liver, not elsewhere classifiedK76.0Type 2 diabetes mellitusE11
- Registration Number
- DRKS00012281
- Lead Sponsor
- Klinik für Gastroenterologie und Rheumatologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 203
Inclusion Criteria
Typ 2 diabetes mellitus
Exclusion Criteria
liver transplantation,
pregnancy/lactation,
malignant disease with restricted life expectancy.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Applicability and correlation of non-invasive diagnostic tests (conventional ultrasound, liver elastography, laboratory based markers of liver fibrosis and anthropometric measures) for characterization of Non-Alcoholic Fatty Liver disease (NAFLD).
- Secondary Outcome Measures
Name Time Method Frequency and patient associated factors for incongruous non-invasive NAFLD tests.<br>